It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of breast cancer, the health regulator said on Friday.

The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with unresectable or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer.

Morgan Pressel's 18th annual Morgan & Friends event raised a record $1,022,000 to support the fight against breast cancer. Pressel, 36, lost her mother Kathy to breast cancer in 2003, and her memory is at the heart of the mission.

Inside Edition' reporter Alison Hall undergoes a double mastectomy, after discovering her breast cancer while on assignment. Alison was covering Olivia Munn's diagnosis by taking cameras along for a screening last year,

During a Case-Based Roundtable event, Laura Huppert, MD, reviewed antibody-drug conjugates for a patient with metastatic breast cancer who had progressed on multiple line of therapy.

Danielle Fishel is sharing an update about her health, saying she has completed “active cancer treatment” following her announcement in August that she was diagnosed with DCIS, which stands for ductal carcinoma in situ and is a form of breast cancer.

Technology could soon do more than assist doctors. Thanks to advancements in cancer-identifying AI, it could actively save lives. A new study recently showcased how AI can revolutionize breast cancer detection, improving accuracy and easing radiologists’ workload.

As cancer treatment costs have increased, identifying and treating early-stage cancer sooner reduces expenses and improves patient outcomes.

Datroway has been approved for unresectable or metastatic HR+, HER2- breast cancer after endocrine therapy and chemotherapy.

Breast cancer detection in its early stages significantly improves survival rates, according to medical experts. While regular screenings remain crucial,